PHI with Pulmonary echinococcosis

How does this condition affect your private health insurance?

Echinococcus-granulosus-Infektion der Lunge, also known as pulmonary hydatid disease, is a parasitic infection caused by the larval stage of the tapeworm Echinococcus granulosus. Humans acquire it by ingesting eggs from contaminated dog feces. In the lungs, it forms slow-growing hydatid cysts, often asymptomatic for years. When symptoms manifest, they include chronic cough, chest pain, dyspnea, and hemoptysis. Complications arise from cyst rupture, potentially causing anaphylaxis, secondary infections, or dissemination. Diagnosis relies on imaging and serology. Treatment typically involves surgical removal of the cyst, often complemented by antiparasitic medication like albendazole, to prevent recurrence and manage symptoms effectively.

PKV Risk Assessment

Slightly Elevated Risk

Impact on Your Insurance Policy

Duration of Illness (Initial)

Symptoms can be insidious, developing over months to years. Once symptomatic or treated, recovery from acute illness and surgery can take several weeks to months.

Duration of Illness (Lifetime)

Potentially a one-time event with successful treatment; however, untreated or incompletely treated cases can lead to chronic illness, recurrence, or long-term complications over many years.

Cost of Treatment (Initial)

High, typically ranging from several thousand to tens of thousands of USD, depending on diagnostic complexity, surgical intervention, hospital stay duration, and antiparasitic drug regimen.

Cost of Treatment (Lifetime)

If cured, primarily involves follow-up costs. In cases of recurrence, complications, or incomplete treatment, lifetime costs can accumulate significantly, requiring repeated interventions and prolonged medication.

Mortality Rate

Low (below 5%) with appropriate and timely medical and surgical treatment. However, severe complications like anaphylaxis from cyst rupture, secondary infections, or disseminated disease can significantly increase mortality risk if untreated.

Risk of Secondary Damages

Moderate to high. Cyst rupture can lead to anaphylactic shock, secondary bacterial infections (e.g., empyema), pleural effusions, bronchopleural fistulas, and potential dissemination to other organs, causing long-term respiratory impairment or systemic issues.

Probability of Full Recovery

High (above 80-90%) with prompt and complete surgical excision of the cyst combined with adjunctive antiparasitic medication. Residual symptoms or complications can occur in some cases.

Underlying Disease Risk

Generally low, as it is an acquired parasitic infection not typically linked to pre-existing human diseases. However, individuals with compromised immune systems might experience more severe or atypical presentations.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.